v6Pep-2

General Information


DRACP ID  DRACP01168

Peptide Name   v6Pep-2

Sequence  CNEWQLKSC

Sequence Length  9

UniProt ID  Not available

PubChem CID  Not available

Origin  Screen of phage display peptide library

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-231 Breast adenocarcinoma Carcinoma Kd=17.69 CD44v6 specifically binds to assay Not available Patent
4T1 Malignant neoplasms of the mouse mammary gland Carcinoma Kd=29.12 CD44v6 specifically binds to assay Not available Patent
PANC-1 Pancreatic ductal adenocarcinoma Carcinoma Kd=6.655 CD44v6 specifically binds to assay Not available Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01168

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C46H71N13O15S2

Absent amino acids  ADFGHIMPRTVY

Common amino acids  C

Mass  125315

Pl  6.14

Basic residues  1

Acidic residues  1

Hydrophobic residues  2

Net charge  0

Boman Index  -1813

Hydrophobicity  -81.11

Aliphatic Index  43.33

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5625

Absorbance 280nm  703.13

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID EP3733685A1

Patent Title  Peptides Binding to Cd44v6 and Use Thereof

Other Iinformation  Patent Application; Family: 6s / 7ex; Family Jurisdictions: EP, KR, US; Legal Status: Pending; Application No: 18889460; Filed: Dec 17, 2018; Published: Nov 4, 2020; Earliest Priority: Dec 15, 2017

Other Published ID  EP3733685A4  KR102194025B1  KR20190072467A  US2021163535A1 




DRACP is developed by Dr.Zheng's team.